Champions Oncology Files 8-K: Board and Officer Changes
Ticker: CSBR · Form: 8-K · Filed: Oct 3, 2024 · CIK: 771856
| Field | Detail |
|---|---|
| Company | Champions Oncology, INC. (CSBR) |
| Form Type | 8-K |
| Filed Date | Oct 3, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, governance, filing
TL;DR
Champions Oncology 8-K: Board shakeup, new execs, and old names resurface.
AI Summary
Champions Oncology, Inc. filed an 8-K on October 3, 2024, reporting changes in its board of directors and executive officers, including the election of new directors and potential adjustments to compensatory arrangements. The filing also notes the company's previous names, Champions Biotechnology, Inc., Champions Sports Inc., and International Group Inc., with the most recent name change occurring on February 20, 2007.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and governance can introduce uncertainty about the company's future direction and stability.
Key Players & Entities
- CHAMPIONS ONCOLOGY, INC. (company) — Registrant
- October 3, 2024 (date) — Filing Date
- CHAMPIONS BIOTECHNOLOGY, INC. (company) — Former Company Name
- CHAMPIONS SPORTS INC (company) — Former Company Name
- INTERNATIONAL GROUP INC (company) — Former Company Name
- February 20, 2007 (date) — Date of Name Change
FAQ
What specific changes were made to the board of directors and executive officers?
The filing indicates the election of directors and appointment of certain officers, but the specific details of these changes are not provided in the provided text.
What is the primary reason for this 8-K filing?
This 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements.
When was the most recent name change for Champions Oncology, Inc.?
The most recent name change was on February 20, 2007, when the company was formerly known as Champions Biotechnology, Inc.
What is the company's state of incorporation and IRS Employer Identification Number?
The company is incorporated in Delaware and its IRS Employer Identification Number is 52-1401755.
What is the business address of Champions Oncology, Inc.?
The business address is 855 N. Wolfe Street, Suite 619, Baltimore, MD 21205.
Filing Stats: 425 words · 2 min read · ~1 pages · Grade level 11.9 · Accepted 2024-10-03 11:12:38
Key Financial Figures
- $0.001 — ich Registered Common Stock, par value $0.001 per share CSBR The Nasdaq Stock Market
Filing Documents
- csbr-20241003.htm (8-K) — 31KB
- 0001628280-24-042039.txt ( ) — 154KB
- csbr-20241003.xsd (EX-101.SCH) — 2KB
- csbr-20241003_def.xml (EX-101.DEF) — 3KB
- csbr-20241003_lab.xml (EX-101.LAB) — 21KB
- csbr-20241003_pre.xml (EX-101.PRE) — 13KB
- csbr-20241003_htm.xml (XML) — 2KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CHAMPIONS ONCOLOGY, INC. (Registrant) Date: October 3, 2024 By: /s/ Ronnie Morris Ronnie Morris Chief Executive Officer